Plus   Neg

Regeneron Pharmaceuticals Q1 adjusted earnings Miss Estimates

Regeneron Pharmaceuticals (REGN) revealed a profit for first quarter that dropped from last year.

The company's profit totaled $461.1 million, or $3.99 per share. This compares with $478.0 million, or $4.16 per share, in last year's first quarter.

Excluding items, Regeneron Pharmaceuticals reported adjusted earnings of $517.7 million or $4.45 per share for the period.

Analysts had expected the company to earn $5.46 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 13.2% to $1.71 billion from $1.51 billion last year.

Regeneron Pharmaceuticals earnings at a glance:

-Earnings (Q1): $517.7 Mln. vs. $536.7 Mln. last year.
-EPS (Q1): $4.45 vs. $4.67 last year.
-Analysts Estimate: $5.46
-Revenue (Q1): $1.71 Bln vs. $1.51 Bln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT